Stay updated on Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The new screenshot adds another version entry to the Record History, indicating an update to the record. No core study content or essential details changed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:06:12.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    12%
    Check dated 2025-10-05T09:06:07.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:05:13.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Updates to revision v3.0.2 include a new date (2025-09-08) and a Study Status entry for 2025-09-04, while older date (2024-11-29), v3.0.1, and a Back to Top element were removed.
    Difference
    2%
    Check dated 2025-09-13T17:09:41.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-06T14:38:54.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    19%
    Check dated 2025-08-30T11:25:00.000Z thumbnail image

Stay in the know with updates to Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.